An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
| Drug | Glycerol phenylbutyrate (Ravicti) |
|---|---|
| Indication | Use as a nitrogen-binding agent for chronic management of adult and pediatric patients ≥2 years of age with urea cycle disorders who cannot be managed by dietary protein restriction and/or amino acid supplementation alone |
| Reimbursement request | As per indication |
| Dosage form(s) | Oral liquid, 1.1 g/mL |
| NOC Date | March 18, 2016 |
| Manufacturer | Horizon Therapeutics Canada |
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Your browsing activity is empty.
Activity recording is turned off.
See more...
